What this means for Washington State Medicare beneficiaries in 2026: For a full overview of how Medicare Parts A, B, C, and D work together in Washington, see our guide: Medicare Parts A, B, C & D in Washington State Explained
CJC-1295 (no DAC) is often studied in combination with other secretagogues like Ipamorelin for potential synergistic effects
The primary endpoint was percent change in body weight from randomization (week 36) to the end of the trial (week 88)
Eli Lilly filed a lawsuit against the company in April 2025 for allegedly selling unapproved tirzepatide products
The regulatory profile is unambiguous: BPC-157 is not registered as a drug and since 2022 has been on the WADA list in category S0
"Ozempic works because you eat less food, yeah